- $2.49bn
- $3.01bn
- $777.71m
- 65
- 39
- 48
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 327 | 411 | 535 | 685 | 778 |
Cost of Revenue | |||||
Gross Profit | 236 | 290 | 366 | 471 | 546 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 373 | 486 | 658 | 797 | 912 |
Operating Profit | -46 | -74.1 | -123 | -112 | -135 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -53.8 | -96.9 | -136 | -122 | -150 |
Provision for Income Taxes | |||||
Net Income After Taxes | -53.8 | -98.8 | -146 | -125 | -149 |
Net Income Before Extraordinary Items | |||||
Net Income | -53.8 | -98.8 | -146 | -125 | -149 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -53.8 | -98.8 | -146 | -125 | -149 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.09 | -1.9 | -2.42 | -2.13 | -1.31 |